Quilter Plc Has $14.32 Million Stock Position in Danaher Co. (NYSE:DHR)

Quilter Plc grew its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 4.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 62,371 shares of the conglomerate's stock after buying an additional 2,746 shares during the quarter. Quilter Plc's holdings in Danaher were worth $14,317,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. FMR LLC raised its position in shares of Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after acquiring an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after acquiring an additional 535,254 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after acquiring an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. raised its position in shares of Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock valued at $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $74,551,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Danaher Stock Performance

Shares of DHR traded up $1.38 during trading hours on Thursday, reaching $203.56. 7,198,721 shares of the company's stock traded hands, compared to its average volume of 4,471,049. The business's fifty day simple moving average is $230.49 and its two-hundred day simple moving average is $250.28. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The firm has a market capitalization of $147.03 billion, a price-to-earnings ratio of 38.55, a P/E/G ratio of 2.68 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the company earned $2.09 earnings per share. Analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.53%. Danaher's dividend payout ratio is currently 20.45%.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

DHR has been the topic of several research reports. Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research report on Wednesday, October 23rd. KeyCorp upped their price target on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. Wolfe Research raised Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Barclays dropped their target price on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Finally, TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.